Gibson, Dunn & Crutcher, Australian firm Corrs Chambers Westgarth and King & Wood Mallesons are playing lead roles on a $750 million deal that will see a consortium led by Goldman Sachs Private Equity Group and Queensland Investment Corp. acquire a majority stake in Brisbane-based health care company Icon Cancer Care Group.
In the deal announced in late May, the U.S. investment bank and the Queensland state-backed asset manager teamed up with Chinese buyout firm Pagoda Investment to buy a majority stake in Icon from Sydney-based investor Quadrant Private Equity. Details of the deal were not disclosed but several media outlets, including Bloomberg and The Australian, reported its value at A$1 billion, or $750 million.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
